Page 66 - AIH-1-2
P. 66

Artificial Intelligence in Health                                       AI in AD – Diagnosis and monitoring



              Developing instructional programs to help doctors   Ethics approval and consent to participate
            successfully use and interpret AI products and services
            through continuous education is another important factor   Not applicable.
            to take into account. Although AI holds great potential to   Consent for publication
            improve diagnosis, there are several possible drawbacks,
            including the risk of false diagnoses and erroneous risk   Not applicable.
            assessments. Establishing  formal collaboration between
            industry, the research community, and health-care systems   Availability of data
            is critical. Such collaboration is necessary to handle every   Not applicable.
            important facet  of  AI  and guarantee  a  smooth  transfer
            from academic research to practical implementation.  References

              In the near future, physicians and AI-guided computers   1.   Huchegowda R, Huchegowda S, Pramer J, et al. Review on
            will probably work closely together. AI has the ability to   artificial intelligence and applications in healthcare. Neuro
            change clinical management by assisting physicians in   Open J. 2019;6(1):e1-e4.
            analyzing patient data on an individual basis, identifying      doi: 10.17140/noj-6-e010
                                                      108
            trends in different diagnostic test results, and more.  In   2.   Lopez-Jimenez F, Attia Z, Arruda-Olson AM, et al. Artificial
            this setting, the role of medical experts in interdisciplinary   intelligence in cardiology: Present and future.  Mayo  Clin
            teams  becomes essential. The implementation  of  AI   Proc. 2020;95(5):1015-1039.
            algorithms requires the collection and analysis of large      doi: 10.1016/j.mayocp.2020.01.038
            amounts of data, which calls for interpretation within a
            particular healthcare setting. The domain of “augmented   3.   Rajpurkar P, Chen E, Banerjee O, Topol EJ. AI in health and
            intelligence,” where people and machines cooperate to   medicine. Nat Med. 2022;28(1):31-38.
            enhance the diagnostic workflow, share judgments, and      doi: 10.1038/s41591-021-01614-0
            work in concert, is where clinicians and computers can   4.   Cichocki A. Chief Editor’s foreword to the inaugural issue of
            effectively collaborate. This collaboration has the potential   artificial intelligence in health. AIH. 2024;1(1):2463.
            to effectively minimize emotional and economic burdens,      doi: 10.36922/aih.2463
            leading to more efficient patient care in the health sector.
                                                               5.   Esteva A, Kuprel B, Novoa RA,  et al. Dermatologist-level
            Acknowledgments                                       classification of skin cancer with deep neural networks.
                                                                  Nature. 2017;542(7639):115-118.
            Pratheek Jain and Vinay Alva express gratitude towards
            Pavara  Institute of Medical  Sciences  (PIMS),  Loni,      doi: 10.1038/nature21056
            Maharastra, for research support. All authors thank the   6.   DaVeiga SP. Epidemiology of atopic dermatitis:  A  review.
            Management of Alva’s Education Foundation (AEF),      Allergy Asthma Proc. 2012;33(3):227-234.
            Moodubidire, ATMA Research Centre, Vidyagiri, and BLDE      doi: 10.2500/aap.2012.33.3569
            University, Karnataka, for the constant research motivation.
                                                               7.   Williams H,  Stewart A,  Von  Mutius  E, Cookson W,
            Funding                                               Anderson HR, International Study of Asthma and Allergies
                                                                  in Childhood (ISAAC) Phase One and Three Study Groups.
            None.                                                 Is eczema really on the increase worldwide? J Allergy Clin
                                                                  Immunol. 2008;121(4):947-954.e15.
            Conflict of interest
                                                                  doi: 10.1016/j.jaci.2007.11.004
            The authors declare that they have no conflicts of interest.  8.   Furue M, Chiba T, Takeuchi S. Current status of atopic
            Author contributions                                  dermatitis in Japan. Asia Pac Allergy. 2011;1(2):64-72.
                                                                  doi: 10.5415/apallergy.2011.1.2.64
            Conceptualization:  Farhan Zameer, Raghavendra Hallur
               Laxmanashetty                                   9.   Williams HC, Strachan DP. The natural history of childhood
            Data curation: Ravish Huchegowda, Ali Jawad Akki      eczema: Observations from the British 1958 birth cohort
            Writing – original draft:  Pratheek  Jain,  Kounaina  Khan,    study. Br J Dermatol. 1998;139(5):834-839.
               Vinay Alva                                         doi: 10.1046/j.1365-2133.1998.02501.x
            Writing – review & editing:  Raghu Anjanapura      10.  Paternoster L, Savenije OE, Heron J, et al. Identification of
               Venkataramanaiah,  Muthuchelian  Krishnasamy,      atopic dermatitis subgroups in children from 2 longitudinal
               Dilip Apturkar                                     birth cohorts. J Allergy Clin Immunol. 2018;141(3):964-971.


            Volume 1 Issue 2 (2024)                         60                               doi: 10.36922/aih.2775
   61   62   63   64   65   66   67   68   69   70   71